Sept 3 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental candidates that target ...
Given the complexity and seriousness of these cases, and the severity of the consequences for defendants who are convicted of homicide or attempted homicide on the basis of joint responsibility for ...
The KTC MegPad A25Q5 has so much potential. It looks great and, on paper, everything about it seems to point at a product ...
Sept 5 (Reuters) - Global equity funds drew their biggest weekly inflows in three weeks in the period to September 3, lifted by growing expectations of a Federal Reserve rate cut this month and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback